Abstrakt
To evaluate the role of 2-deoxy-2-(F)fluoro-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT) for selecting patients with extensive ovarian cancer (OC) for neoadjuvant chemotherapy by evaluating predictors of overall survival in patients with stage IIIC/IV OC.
Originalsprog | Engelsk |
---|---|
Tidsskrift | International Journal of Gynecological Cancer |
Vol/bind | 22 |
Udgave nummer | 7 |
Sider (fra-til) | 1163-9 |
Antal sider | 7 |
ISSN | 1048-891X |
DOI | |
Status | Udgivet - 2012 |